Invacare Corporation
IVC · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $165 | $181 | $170 | $189 |
| % Growth | -8.7% | 6.4% | -9.8% | – |
| Cost of Goods Sold | $122 | $133 | $139 | $141 |
| Gross Profit | $44 | $48 | $31 | $48 |
| % Margin | 26.5% | 26.6% | 18.4% | 25.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $54 | $52 | $55 | $59 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $54 | $52 | $55 | $59 |
| Operating Income | -$31 | -$12 | -$26 | -$15 |
| % Margin | -18.8% | -6.6% | -15.3% | -7.8% |
| Other Income/Exp. Net | -$9 | -$5 | -$9 | -$10 |
| Pre-Tax Income | -$40 | -$21 | -$33 | -$21 |
| Tax Expense | $1 | -$0 | $1 | $1 |
| Net Income | -$41 | -$21 | -$34 | -$22 |
| % Margin | -24.9% | -11.3% | -20.2% | -11.6% |
| EPS | -1.08 | -0.56 | -0.91 | -0.61 |
| % Growth | -92.9% | 38.5% | -49.2% | – |
| EPS Diluted | -1.08 | -0.56 | -0.91 | -0.61 |
| Weighted Avg Shares Out | 38 | 37 | 38 | 36 |
| Weighted Avg Shares Out Dil | 38 | 37 | 38 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | -$0 | -$0 | $0 | $0 |
| Interest Expense | $9 | $9 | $7 | $6 |
| Depreciation & Amortization | $21 | -$16 | $5 | $5 |
| EBITDA | -$10 | -$28 | -$24 | -$11 |
| % Margin | -6% | -15.2% | -14.1% | -5.6% |